Research undertaken at the UW-Madison George M. O’Brien Center for Benign Urology Research is dedicated to improving urologic health in aging men. The center is a multi-site research cooperative between the University of Wisconsin-Madison, University of Massachusetts-Boston, University of Texas-Southwestern, and the National Institutes of Health (NIH).
In addition to building research tools and improving technology for benign urology research, the U54 O’Brien Center for Benign Urologic Research also supports basic science and translational research.
The O’Brien Centers were established by the NIDDK in 1987 as P50 programs and worked independently. They were converted to the U54 mechanism in 2012 to encourage collaboration between funded centers and sharing with the larger research community with the following mission:
- Support the next generation of urologic researchers by providing meaningful education, support, and mentoring
- Cultivate new research tools and ideas by expanding the collaborative network within and outside of the traditional urologic research field
- Enhance knowledge of mechanisms associated with normal development, function, and disease pathology related to the urinary tract, kidney, and prostate
- Translate knowledge and tools generated from our collaborations to the clinical setting to reduce the burden of benign urologic illness by developing and testing therapies to better treat, manage, and prevent these diseases
The goals of the O’Brien Center are to:
- Identify factors that cause urinary dysfunction in aging men
- Build consensus around research approaches to model urinary dysfunction in rodents
- Provide opportunities for established investigators to transition into the field of benign urology
- Secure the future of urologic research by promoting development of the next generation of urologic researchers
- Disseminate urologic research knowledge through seminars, workshops and symposia
OTHER U54 O’BRIEN CENTERS FOR BENIGN UROLOGY RESEARCH
The Columbia University O’Brien Urology Center brings together research programs in Human Genetics and Mouse models to address the causes of congenital urinary tract malformations.
The University of Pittsburgh O'Brien Urology Research Center's mission is to identify new targets for developing novel preventative & therapeutic treatment approaches for BPH.
On July 10, 2023, Lori Uttech-Hanson came on board as the O’Brien Center’s Clinical Research Center Administrator with a part-time role on the CAIRIBU Interactions Core. Before joining the team, Lori served as the Director …August 25, 2023
Congratulations to Dr. Diego Hernando (UW O’Brien Center Project 1 Co-Investigator & Director of Quantitative Body MR in the UW Departments of Radiology and Medical Physics) for being awarded a UW-Madison Vilas Faculty Early-Career Investigator …April 10, 2023
Congratulations to Dr. Diego Hernando (UW O’Brien Center Project 1 Co-Investigator & Director of Quantitative Body MR in the UW Departments of Radiology and Medical Physics) for being awarded a UW-Madison Office of the Vice …April 10, 2023
Congratulations to Ruiqi Geng, PhD Candidate in the laboratory of Dr. Diego Hernando (UW O’Brien Center Project 1 Co-Investigator & Director of Quantitative Body MR in the UW Departments of Radiology and Medical Physics) for …April 10, 2023
Dr. William Ricke (UW O’Brien Center Director) presented “Identifying New Cellular and Molecular Targets for the Medical Treatment of BPH/LUTS” at this year’s Columbia O’Brien Center Symposium in New York, NY. Great work, Dr. Ricke!April 10, 2023
- More News